Personalized Medicine – From Promise to Reality                 

Progress in a number of molecular profiling technologies including proteomic profiling, metabolomics analysis and genetic testing has moved the promised hopes of personalized Medicine into a reality.

DueNorth provides specialized services to biotech companies, diagnostic and device companies, research agencies and scientific groups to transition translational research into clinical validation, clinical research confirmation and marketing approval.

DueNorth designs, develops and implements high-impact clinical research designed to advance personalized medical technology to optimize a patient's preventative and therapeutic care.